| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/02/1997 | US5663295 Analgesic, antidiarrhea |
| 09/02/1997 | US5663294 Anticoagulant oligopeptides or polypeptides |
| 09/02/1997 | US5663293 ICAM-related protein |
| 09/02/1997 | US5663292 Antagonist peptides; regulation of secretion of corticotropin |
| 09/02/1997 | US5663204 Cholecystokinin and gastrin antagonist for appetite regulators, gastrointestinal disorders and nervous system disorders |
| 09/02/1997 | US5663200 Carbamoyl peptide derivatives as viricides |
| 09/02/1997 | US5663171 For use in humans or animals |
| 09/02/1997 | US5663168 Use of compositions for combating tumour diseases |
| 09/02/1997 | US5663153 Immune stimulation by phosphorothioate oligonucleotide analogs |
| 09/02/1997 | US5663150 Cyclopentane-β-amino acid tripeptides |
| 09/02/1997 | US5663149 Anticarcinogenic agents related to dolastatin |
| 09/02/1997 | US5663148 Anaphylatoxin receptor ligands containing lipophilic residues |
| 09/02/1997 | US5663146 Administering a synergistic combination to animals, including humans |
| 09/02/1997 | US5663145 Products for administering an initial high dose of Cetrorelix and producing a combination package for use when treating diseases |
| 09/02/1997 | US5663144 Compounds that bind to p185 and methods of using the same |
| 09/02/1997 | US5663143 Protein which binds and inhibits elastase |
| 09/02/1997 | US5663142 For treating thrombosis, protein s deficiency, sepsis, inflammation and cancer |
| 09/02/1997 | US5663141 Hirudin/polyalkylene glycol conjugates and hirudin muteins |
| 09/02/1997 | US5663140 Parasiticides for humans and livestock |
| 09/02/1997 | US5663139 Inhibitors of retroviral proteases |
| 09/02/1997 | US5663071 An isolated polynucleotide |
| 09/02/1997 | US5663070 Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM |
| 09/02/1997 | US5663064 Ribozymes with RNA protein binding site |
| 09/02/1997 | US5663060 Having procoagulant activity |
| 09/02/1997 | US5663059 Polynucleotide with code, gene expression |
| 09/02/1997 | US5663047 Genetic typing |
| 09/02/1997 | US5662941 Method for treating diseases caused by bacterial microorganisms with a composition containing fluorine F- and lithium LI+ |
| 09/02/1997 | US5662922 Iron-containing composition for the prevention of anaemia and a method for producing the composition |
| 09/02/1997 | US5662917 Release-controlled implantable somatotropin composition |
| 09/02/1997 | US5662910 Antiprotozoa |
| 09/02/1997 | US5662908 Salmonella typhimurium where a hil gene has been modified to alter its invasive phenotype |
| 09/02/1997 | US5662905 Protection against pseudomonas |
| 09/02/1997 | US5662904 Anti-scarring compositions comprising growth factor neutralizing antibodies |
| 09/02/1997 | US5662901 Enzymes for grain treatment to improve digestion by incubation of grain with enzyme |
| 09/02/1997 | US5662896 Directly administering a vector construct which directs the expression of antitumor agents |
| 09/02/1997 | US5662895 Method of administering human pluripotent hematopoietic colony stimulating factor |
| 09/02/1997 | CA1339440C Process for stabilizing human albumin solutions and the solution obtained |
| 09/02/1997 | CA1339416C Insulin derivatives |
| 09/02/1997 | CA1339415C Detection and treatment of infections with immunoconjugates |
| 08/29/1997 | CA2198690A1 Prophylactic/therapeutic composition for secondary cataract |
| 08/29/1997 | CA2198316A1 Treatment of septic shock with anti-tnf antibodies |
| 08/28/1997 | WO1997031122A1 Substance fa-70d, process for producing the same, and uses thereof |
| 08/28/1997 | WO1997031119A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | WO1997031116A2 Recombinant ribonuclease proteins |
| 08/28/1997 | WO1997031114A2 Polynucleotides and aminoacid sequences from staphylococcus aureus |
| 08/28/1997 | WO1997031112A2 Compounds and related methods for modulating potassium ion channels and assays for such compounds |
| 08/28/1997 | WO1997031110A1 Traf family molecule, polynucleotide coding for the molecule, and antibody against the molecule |
| 08/28/1997 | WO1997031109A1 Meltrins |
| 08/28/1997 | WO1997031108A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 08/28/1997 | WO1997031107A2 Human serum lectin - induced apoptosis and method for detecting apoptosis |
| 08/28/1997 | WO1997031099A1 Human beta 2 integrin alpha subunit |
| 08/28/1997 | WO1997031098A1 Human chemokine polypeptides |
| 08/28/1997 | WO1997031025A1 Humanized anti-cd40 monoclonal antibodies and fragments capable of blocking b cell activation |
| 08/28/1997 | WO1997031024A1 Antibody variants |
| 08/28/1997 | WO1997031023A1 Peptide derivatives |
| 08/28/1997 | WO1997031021A1 Oral calcitonin preparation and method for recovering calcitonin from eggshells |
| 08/28/1997 | WO1997031020A1 METHODS AND COMPOSITIONS FOR ENHANCING CELLULAR RESPONSE TO TGF-β LIGANDS |
| 08/28/1997 | WO1997031019A2 Antipathogenic peptides and compositions comprising them |
| 08/28/1997 | WO1997031018A1 Crystal structure of apopain and uses thereof |
| 08/28/1997 | WO1997031016A2 New inhibitors of sh2-mediated processes |
| 08/28/1997 | WO1997031010A1 Receptor protein designated 2f1 |
| 08/28/1997 | WO1997030975A2 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support |
| 08/28/1997 | WO1997030732A1 Liposomal-viral dna complexes for treating disease |
| 08/28/1997 | WO1997030729A1 Drug containing hcv hyperimmune globulins |
| 08/28/1997 | WO1997030725A1 Cochleat delivery vehicles |
| 08/28/1997 | WO1997030724A1 Recombinant tissue plasminogen activator (rtpa) for preventing secondary cataracts following cataract operations |
| 08/28/1997 | WO1997030722A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
| 08/28/1997 | WO1997030721A1 Pharmaceutical composition for immunomodulation based on peptides and adjuvants |
| 08/28/1997 | WO1997030716A1 Anti-helicobacter vaccine complex |
| 08/28/1997 | WO1997030713A1 Method and composition for inhibiting cellular irreversible changes due to stress |
| 08/28/1997 | WO1997030712A1 METHOD FOR INHIBITING NF- kappa B ACTIVATION |
| 08/28/1997 | WO1997030705A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 08/28/1997 | WO1997030587A1 Dna vaccination for induction of suppressive t cell response |
| 08/28/1997 | WO1997026523A3 Detection of a leptin receptor variant and methods for regulating obesity |
| 08/28/1997 | WO1997023612A3 Targeted compounds with cartilage formation-inducing and/or bone formation-inducing activity |
| 08/28/1997 | WO1997022624A3 Cosmetic preparations containing vertebrate proteins and having antibacterial, antimycotical and antiviral action |
| 08/28/1997 | WO1997020051A3 Vectors and methods for gene transfer to cells |
| 08/28/1997 | WO1997019953A3 New lh-rh antagonists with improved effectiveness |
| 08/28/1997 | WO1997019180A3 Vector consisting of a transcriptional regulatory DNA sequence linked to a DNA sequence encoding beta-lactamase for enzyme prodrug therapy |
| 08/28/1997 | WO1997016535A3 Methods for use of mpl ligands with primitive human stem cells |
| 08/28/1997 | WO1997010852A3 Xsns-type bi-functional sulphide-containing sulphonamide chelating agents for radioactive isotopes |
| 08/28/1997 | WO1997009297A3 Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 08/28/1997 | WO1997009068A3 Interactive molecular conjugates |
| 08/28/1997 | DE19608280A1 Causal treatment of infection by human or simian immunodeficiency virus |
| 08/28/1997 | DE19607210A1 Verfahren zur Reinigung von thrombinähnlichen Proteasen aus Schlangengiften A process for purifying thrombin proteases from snake venoms |
| 08/28/1997 | DE19606551A1 rt-PA zur Prävention des Nachstars nach Kataraktoperation rt-PA for the prevention of cataract after cataract surgery |
| 08/28/1997 | CA2247517A1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein |
| 08/28/1997 | CA2247481A1 Use of cell membrane permeants in the treatment of cellular proliferative diseases |
| 08/28/1997 | CA2247461A1 Method and composition for inhibiting cellular irreversible changes due to stress |
| 08/28/1997 | CA2247460A1 Recombinant tissue plasminogen activator (rtpa) for preventing secondary cataracts following cataract operations |
| 08/28/1997 | CA2247113A1 Human chemokine polypeptides |
| 08/28/1997 | CA2247068A1 Crystal structure of apopain and uses thereof |
| 08/28/1997 | CA2247025A1 Antipathogenic peptides and compositions comprising them |
| 08/28/1997 | CA2246359A1 Methods and compositions for protective and therapeutic genetic immunization |
| 08/28/1997 | CA2242809A1 Peptide derivatives |
| 08/28/1997 | CA2241142A1 Liposomal-viral dna complexes for treating disease |
| 08/28/1997 | CA2198534A1 Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists |
| 08/27/1997 | EP0791654A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes |
| 08/27/1997 | EP0791653A1 Human Fc-gamma receptor III |
| 08/27/1997 | EP0791603A2 Pure somatostatin antagonist and methods of use thereof |